(Q54107294)

24 May 2018

title

Modulation by cytokines of induction of oral tolerance to type II collagen. (English)

1 reference

24 May 2018

author name string

Thorbecke GJ

1

1 reference

24 May 2018

Schwarcz R

2

1 reference

24 May 2018

Leu J

3

1 reference

24 May 2018

Huang C

4

1 reference

24 May 2018

Simmons WJ

5

1 reference

24 May 2018

publication date

1 January 1999

1 reference

24 May 2018

published in

Arthritis and Rheumatism

1 reference

24 May 2018

volume

42

1 reference

24 May 2018

issue

1

1 reference

24 May 2018

page(s)

110-118

1 reference

24 May 2018

Systemic tolerance and secretory immunity after oral immunization.

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Collagen arthritis in rats, arthritogenic lymphokines and other aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

The ups and downs of EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Autoimmunity in the eye and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Lack of oral tolerance in C3H/HeJ mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Involvement of endogenous tumor necrosis factor alpha and transforming growth factor beta during induction of collagen type II arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Pharmacologic effects of autacoids on subsets of T cells. Regulation of expression/function of histamine-2 receptors by a subset of suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Tolerogenic forms of auto-antigens and cytokines in the induction of resistance to experimental allergic encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Efficacy of a selective histamine H2 receptor agonist, dimaprit, in experimental models of endotoxin shock and hepatitis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Immunosuppressive and anti-inflammatory properties of interleukin 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Role for autocrine TGF-beta 1 in regulating differentiation of a human leukemic cell line toward osteoclast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Oral tolerance in experimental autoimmune encephalomyelitis: serum and salivary antibody responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Clonal anergy is a potent mechanism of oral tolerance in the suppression of acute antigen-induced arthritis in rats by oral administration of the inducing antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184-198 of bovine type II collagen (CII) expressing a dominant T cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

The role of chemokines in oral tolerance. Abrogation of nonresponsiveness by treatment with antimonocyte chemotactic protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Effects of oral administration of type II collagen on rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Effect of a monoclonal antibody against interleukin-4 on the induction of oral tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Antagonistic effects of endogenous and exogenous TGF-beta and TNF on auto-immune diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Multiple suppressive effects of transforming growth factor beta 1 on the immune response in chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Suppressor T cells with histamine type II receptors in chickens bearing chemically induced fibrosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Alleviation of immunosuppression in vitro by recombinant platelet factor 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Suppression of collagen induced arthritis by oral administration of type II collagen: changes in immune and arthritic responses mediated by active peripheral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Differential effects of interleukin‐10 on the expression of HLA class II and CD1 molecules induced by granulocyte/macrophage colony‐stimulating factor/interleukin‐4

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

Oral Tolerance to Myelin Basic Protein Induces Regulatory TGF-β-Secreting T Cells in Peyer's Patches of SJL Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199901%2942%3A1%3C110%3A%3AAID-ANR14%3E3.0.CO%3B2-M

10.1002/1529-0131(199901)42:1<110::AID-ANR14>3.0.CO;2-M

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018